GPA33-CC
N/A
Report date: 2026/05/18 20:02:07
NME
Base Information
Drug NameGPA33-CC
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSmartnuclide Biopharma
China Registration ClassN/A
Develop Information
Active CompaniesSmartnuclide Biopharma
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A